Applied Therapeutics, Inc. (APLT)
USD 1.08
(-1.82%)
USD 1.08
(-1.82%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -55.17 Million | -78.09 Million | -90.72 Million | -78.2 Million | -36.3 Million | -11.18 Million |
| Net Income | -119.76 Million | -82.5 Million | -105.58 Million | -93.96 Million | -45.51 Million | -16.52 Million |
| Depreciation & Amortization | 353 Thousand | 443 Thousand | 415 Thousand | 380 Thousand | 23 Thousand | - |
| Deferred income taxes | 2.79 Million | - | - | 2.55 Million | - | - |
| Stock-based compensation | 7.36 Million | 9.6 Million | 11.17 Million | 8.02 Million | 6.17 Million | 272 Thousand |
| Change in working capital | -1.44 Million | -8.84 Million | 3.66 Million | 5.15 Million | 3.23 Million | 2.06 Million |
| Other non-cash items | 55.52 Million | 3.65 Million | -404 Thousand | -360 Thousand | -218 Thousand | 3 Million |
| Investing Cash Flow | 13.87 Million | 13.17 Million | 12.43 Million | -19.46 Million | -20 Million | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -64.21 Million | -121.58 Million | -134.65 Million | -20 Million | - |
| Sales/Maturities of investments | 13.87 Million | 77.38 Million | 134.02 Million | 115.19 Million | - | - |
| Other Investing Activities | 13.87 Million | 13.17 Million | 12.43 Million | -19.46 Million | -20 Million | - |
| Financing Cash Flow | 74.54 Million | 27.69 Million | 74.71 Million | 136.29 Million | 56.41 Million | 26.65 Million |
| Debt repayment | -1.85 Million | -3.27 Million | -4.71 Million | -2.14 Million | - | -6 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -2.49 Million | - |
| Common Stock Issuance | 74.85 Million | 27.81 Million | 75 Million | 135.71 Million | 55.71 Million | 47 Thousand |
| Other Financing Activities | 1.54 Million | 3.15 Million | 74.71 Million | 136.29 Million | 3.2 Million | 26.65 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -2.79 Million | -4.92 Million | 8.82 Million | -8.04 Million | 5.75 Million | 2.3 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 1.35 Million | -3.91 Million | -5.15 Million | 13.19 Million | -2.52 Million | -238 Thousand |
| Cash at beginning of period | 16.65 Million | 53.88 Million | 57.46 Million | 18.85 Million | 18.74 Million | 3.27 Million |
| Cash at end of period | 49.89 Million | 16.65 Million | 53.88 Million | 57.46 Million | 18.85 Million | 18.74 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 33.24 Million | -37.23 Million | -3.57 Million | 38.61 Million | 102 Thousand | 15.47 Million |
| Free Cash Flow | -55.17 Million | -78.09 Million | -90.72 Million | -78.2 Million | -36.3 Million | -11.18 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.89 Million | -83.93 Million | -119.76 Million | -37.67 Million | -42.37 Million | -29.57 Million |
| Depreciation & Amortization | 122 Thousand | 119 Thousand | 353 Thousand | 6000.00 | 118 Thousand | 116 Thousand |
| Deferred income taxes | - | - | 2.79 Million | -41.8 Million | 27.66 Million | 14.13 Million |
| Stock-based compensation | 1.89 Million | 2.37 Million | 7.36 Million | 1.62 Million | 1.83 Million | 1.84 Million |
| Change in working capital | -4.81 Million | -1.13 Million | -1.44 Million | 1.7 Million | -1.85 Million | -2.08 Million |
| Other non-cash items | -20.97 Million | 65.75 Million | 55.52 Million | 59.14 Million | -121 Thousand | -884 Thousand |
| Investing Cash Flow | - | - | 13.87 Million | - | - | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | 13.87 Million | - | - | - |
| Other Investing Activities | - | - | 13.87 Million | - | - | - |
| Financing Cash Flow | -1.69 Million | 115.49 Million | 74.54 Million | 29.44 Million | 16.56 Million | 29.15 Million |
| Debt repayment | - | -311 Thousand | -1.85 Million | -465 Thousand | -465 Thousand | -306 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.69 Million | - | - | - | - | - |
| Common Stock Issuance | -1.69 Million | 115.8 Million | 74.85 Million | 29.9 Million | 6.71 Million | 27.91 Million |
| Other Financing Activities | 310 Thousand | 8.74 Million | 1.54 Million | 3000.00 | 10.31 Million | 1.54 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 414 Thousand | 527 Thousand | -2.79 Million | -4.26 Million | 1.31 Million | -868 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -5.22 Million | -1.66 Million | 1.35 Million | 5.96 Million | -3.17 Million | -1.22 Million |
| Cash at beginning of period | 146.48 Million | 37.45 Million | 16.65 Million | 37.45 Million | 35.61 Million | 22.91 Million |
| Cash at end of period | 122.19 Million | 146.48 Million | 49.89 Million | 49.89 Million | 37.45 Million | 35.61 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -24.28 Million | 109.02 Million | 33.24 Million | 12.44 Million | 1.84 Million | 12.69 Million |
| Free Cash Flow | -22.59 Million | -18.91 Million | -55.17 Million | -17 Million | -14.72 Million | -16.45 Million |
9525
0757
3086
PROK
KCPSUGIND
SRXXF